Catalyst Wire Dossier Catalyst Wire Dossier

Etermis 4

· Merz Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Etermis 4, covering 2018-05-23 to 2018-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation [NA]

See pricing